therapeutic action: serotonergic modulation

Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder

Researchers tested whether psilocybin mushrooms could help treat obsessive-compulsive disorder (OCD) using mice. They found that psilocybin reduced compulsive burying behavior in mice, similar to how approved OCD medications work. The study revealed that this anti-compulsive effect works through different brain mechanisms than previously thought, and that combining psilocybin with another drug called buspirone might block psychedelic effects while keeping therapeutic benefits.

Read More »

Synthesis and bioactivity of psilocybin analogues containing a stable carbon–phosphorus bond

Researchers created new chemical versions of psilocybin (the active compound in magic mushrooms) that cannot be broken down by the body’s natural enzymes in the same way. They tested these new compounds to see if they could help with depression and anxiety by targeting specific brain receptors. The best compound worked well on the intended brain receptors but importantly showed less activity on a heart-related receptor, potentially making it safer than natural psilocybin.

Read More »
Scroll to Top